Abzena acquires PacificGMP of San Diego for US$7.7m in cash

摘要

Abzena, a UK life sciences company located in Cambridge, has acquired PacificGMP a privately held contract biopharmaceutical development and manufacturing company (CDMO) based in San Diego, CA, US, for US$7.7m (￡4.98m) in cash. An incentive scheme will see PacificGMP's management receive up to 5.12 million Abzena ordinary shares (5.3% of the current issued share capital) over the next two years, depending on performance.